FGF-2 protects cardiomyocytes from doxorubicin damage via protein kinase C-dependent effects on efflux transporters.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Mark W. Nachtigal Elissavet Kardami |
| Publication date | January 22, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |